Rheumatology

June 30, 2020

There are three traditional models of physician-patient decision-making. In rheumatology, patients overwhelmingly prefer a collaborative approach. In today's column, we review the decision-making process in the doctor's office.

June 25, 2020

New research published in Arthritis and Rheumatology shows that vitamin D and marine omega‐3 fatty acids (n‐3 FA) do not offer long-term relief from knee pain, stiffness or function in older adults with chronic knee pain.

June 12, 2020

June 11, 2020

Insulin resistance is independently associated with body mass index and synovitis in rheumatoid arthritis patients, shows new research published in Arthritis and Rheumatology.

June 11, 2020

An expert consensus on the first clinical practice recommendations for platelet-rich plasma (PRP) injections in knee osteoarthritis was presented at the European Congress of Rheumatology annual meeting.

June 10, 2020

A wide range of techniques are used in research to assess bone density and quality, but dual-energy X-ray absorptiometry (DXA) is likely to remain the standard procedure used in clinical practice for the foreseeable future for most patients, predicts the co-author of a recent review of imaging-based techniques for assessing bone in rheumatology.

June 10, 2020

Researchers report that methotrexate with a tumor necrosis factor inhibitor may be best for biologic naive rheumatoid arthritis patients.

June 10, 2020

Rheumatologists should feel more confident in recommending vaccination against herpes zoster to patients with rheumatoid arthritis after a study suggested that the recently approved recombinant adjuvanted vaccine was well tolerated in this group of patients.

June 10, 2020

COVID-19 is delaying and disrupting the treatment of many patients with osteoporosis, so the American Society for Bone and Mineral Research (ASBMR) set up a steering committee of bone specialists to consider how best to manage these patients.

June 10, 2020

One in a 100 rheumatoid arthritis patients with high disease activity will develop a venous thromboembolism, a more than twofold increase compared to patients in remission, according to results from a Swedish cohort study presented at the European Congress of Rheumatology (EULAR) annual meeting last week.